| OMIM ID: | `OMIM ID 600804
`_ |
Allelic Variants (Selected Examples)
.0001 DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO
In a large-scale exon resequencing of the MTNR1B gene in 7,632 Europeans, including 2,186 individuals with type 2 DIABETES (T2D; 125853), Bonnefond et al. (2012) identified a G-to-C transversion at genomic coordinate Chr11:92,342,663 (NCBI36), resulting in an ala42-to-pro (A42P) substitution in the predicted transmembrane domain I. The mutation is rare, with a minor allele frequency of less than 0.1%, and functional analysis in HEK293 cells demonstrated that the A42P variant has no I(125)MLT binding ability and does not activate downstream G(i)-protein-dependent or ERK1 (601795)/2 (176948) signaling pathways. Analysis of this and 3 other complete loss-of-function MTNR1B variants (L60R, 600804.0002; P95L, 600804.0003; and Y308S, 600804.0004) as a pool in 11,854 individuals, including 5,967 with T2D, demonstrated their association with T2D (odds ratio, 3.88; p = 5.37 x 10(-3)).
.0002 DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO
In a large-scale exon resequencing of the MTNR1B gene in 7,632 Europeans, including 2,186 individuals with type 2 DIABETES (T2D; 125853), Bonnefond et al. (2012) identified a T-to-G transversion at genomic coordinate Chr11:92,342,718 (NCBI36), resulting in a leu60-to-arg (L60R) substitution in the predicted transmembrane domain I. The mutation is rare, with a minor allele frequency of less than 0.1%, and functional analysis in HEK293 cells demonstrated that the L60R variant has no I(125)MLT binding ability and does not activate downstream G(i)-protein-dependent or ERK1 (601795)/2 (176948) signaling pathways. Analysis of this and 3 other complete loss-of-function MTNR1B variants (A42P, 600804.0001; P95L, 600804.0003; and Y308S, 600804.0004) as a pool in 11,854 individuals, including 5,967 with T2D, demonstrated their association with T2D (odds ratio, 3.88; p = 5.37 x 10(-3)).
.0003 DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO
In a large-scale exon resequencing of the MTNR1B gene in 7,632 Europeans, including 2,186 individuals with type 2 DIABETES (T2D; 125853), Bonnefond et al. (2012) identified a C-to-T transition at genomic coordinate Chr11:92,354,321 (NCBI36), resulting in a pro95-to-leu (P95L) substitution in the predicted transmembrane domain II. The mutation is rare, with a minor allele frequency of less than 0.1%, and functional analysis in HEK293 cells demonstrated that the P95L variant has no I(125)MLT binding ability and does not activate downstream G(i)-protein-dependent or ERK1 (601795)/2 (176948) signaling pathways. Analysis of this and 3 other complete loss-of-function MTNR1B variants (A42P, 600804.0001; L60R, 600804.0002; and Y308S, 600804.0004) as a pool in 11,854 individuals, including 5,967 with T2D, demonstrated their association with T2D (odds ratio, 3.88; p = 5.37 x 10(-3)).
.0004 DIABETES MELLITUS, TYPE 2, SUSCEPTIBILITY TO
In a large-scale exon resequencing of the MTNR1B gene in 7,632 Europeans, including 2,186 individuals with type 2 DIABETES (T2D; 125853), Bonnefond et al. (2012) identified a A-to-C transversion at genomic coordinate Chr11:92,354,963 (NCBI36), resulting in a tyr308-to-ser (Y308S) substitution within a conserved motif in the predicted transmembrane domain VII. The mutation is rare, with a minor allele frequency of less than 0.1%, and functional analysis in HEK293 cells demonstrated that the Y308S variant has no I(125)MLT binding ability and does not activate downstream G(i)-protein-dependent or ERK1 (601795)/2 (176948) signaling pathways. Analysis of this and 3 other complete loss-of-function MTNR1B variants (A42P, 600804.0001; L60R, 600804.0002; and P95L, 600804.0003) as a pool in 11,854 individuals, including 5,967 with T2D, demonstrated their association with T2D (odds ratio, 3.88; p = 5.37 x 10(-3)).
Recent articles:
- Rasmussen-Torvik LJ et al. “Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA).” Genet Epidemiol. 2012 May;36(4):384-91. PMID 22508271
- Deming SL et al. “Melatonin pathway genes and breast cancer risk among Chinese women.” Breast Cancer Res Treat. 2012 Apr;132(2):693-9. PMID 22138747
- Kristiansson K et al. “Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.” Circ Cardiovasc Genet. 2012 Apr 1;5(2):242-9. PMID 22399527
- Vlassi M et al. “The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population.” Hormones (Athens). 2012 Jan-Mar;11(1):70-6. PMID 22450346
- Kwak SH et al. “A genome-wide association study of gestational diabetes mellitus in Korean women.” Diabetes. 2012 Feb;61(2):531-41. PMID 22233651
- Kettunen J et al. “Genome-wide association study identifies multiple loci influencing human serum metabolite levels.” Nat Genet. 2012 Jan 29;44(3):269-76. PMID 22286219
- Bonnefond A et al. “Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.” Nat Genet. 2012 Jan 29;44(3):297-301. PMID 22286214
- Wang Y et al. “Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a Chinese population.” PLoS One. 2011;6(11):e26953. PMID 22096510
- Kim YJ et al. “Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.” Nat Genet. 2011 Sep 11;43(10):990-5. PMID 21909109
- Song JY et al. “Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents.” Obes Facts. 2011;4(3):197-203. PMID 21701235
Top Pubmed articles linked to gene MTNR1B matching any search term:
- Peter I et al. “Association of Type 2 Diabetes Susceptibility Loci With One-Year Weight Loss in the Look AHEAD Clinical Trial.” Obesity (Silver Spring). 2012 Aug;20(8):1675-82. PMID 22307069
- Liao S et al. “Association of Genetic Variants of Melatonin Receptor 1B with Gestational Plasma Glucose Level and Risk of Glucose Intolerance in Pregnant Chinese Women.” PLoS One. 2012;7(7):e40113. PMID 22768333
- Linder K et al. “Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals.” PLoS One. 2012;7(6):e38224. PMID 22768041
- Hotta K et al. “Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography.” J Hum Genet. 2012 May;57(5):305-10. PMID 22377712
- Rasmussen-Torvik LJ et al. “Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA).” Genet Epidemiol. 2012 May;36(4):384-91. PMID 22508271
- Grimsby JL et al. “Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III).” BMC Med Genet. 2012 Apr 27;13(1):30. PMID 22540250
- Winkler C et al. “Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes.” PLoS One. 2012;7(4):e35410. PMID 22558147
- Deming SL et al. “Melatonin pathway genes and breast cancer risk among Chinese women.” Breast Cancer Res Treat. 2012 Apr;132(2):693-9. PMID 22138747
- Vlassi M et al. “The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population.” Hormones (Athens). 2012 Jan-Mar;11(1):70-6. PMID 22450346
- Kwak SH et al. “A genome-wide association study of gestational diabetes mellitus in Korean women.” Diabetes. 2012 Feb;61(2):531-41. PMID 22233651
- Bonnefond A et al. “Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.” Nat Genet. 2012 Jan 29;44(3):297-301. PMID 22286214
- Kim YJ et al. “Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.” Nat Genet. 2011 Sep 11;43(10):990-5. PMID 21909109
- Takahashi Y et al. “Lack of association between adolescent idiopathic scoliosis and previously reported single nucleotide polymorphisms in MATN1, MTNR1B, TPH1, and IGF1 in a Japanese population.” J Orthop Res. 2011 Jul;29(7):1055-8. PMID 21308753
- Song JY et al. “Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents.” Obes Facts. 2011;4(3):197-203. PMID 21701235
- Reinehr T et al. “Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents.” Pediatr Diabetes. 2011 Jun;12(4 Pt 2):435-41. PMID 21366812
- Holzapfel C et al. “Association of a MTNR1B gene variant with fasting glucose and HOMA-B in children and adolescents with high BMI-SDS.” Eur J Endocrinol. 2011 Feb;164(2):205-12. PMID 21059861
- de Miguel-Yanes JM et al. “Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.” Diabetes Care. 2011 Jan;34(1):121-5. PMID 20889853
- Soranzo N et al. “Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.” Diabetes. 2010 Dec;59(12):3229-39. PMID 20858683